S-1/A: Buda Juice Targets NYSE Listing with $20M IPO for UltraFresh Juice Expansion

Buda Juice, Inc. is launching its initial public offering to raise up to $20 million, aiming to expand its 'UltraFreshTM' cold-crafted juice production and distribution across the U.S. while converting to a Delaware corporation.

Summary

• An Initial Public Offering (IPO) of 2,666,667 shares of common stock is being undertaken, with an estimated offering price between $7.50 and $9.00 per share.
• Net proceeds to the company are estimated at $18,083,179 without the over-allotment option, or $20,873,179 with full exercise of the over-allotment.
• Proceeds will be used to develop and furnish new production plants in South Carolina (projected 2026) and Arizona/Nevada (projected 2027), expand the existing Texas plant, and redeem 500,000 shares from CEO Horatio Lonsdale-Hands for $3,750,000.
• The company, Buda Juice, LLC, is converting to a Delaware corporation named Buda Juice, Inc. immediately prior to the IPO closing.
• An application has been made to list the common stock on the New York Stock Exchange (NYSE) under the symbol BUDA, with the closing of the offering contingent upon successful listing.
• Revenue grew from $5.6 million in 2022 to $11.2 million in 2024, representing a 41.8% Compound Annual Growth Rate (CAGR).
• Net sales for the nine months ended September 30, 2025, increased by 14.3% to $9,714,000, compared to $8,502,000 for the same period in 2024.
• Net income for the nine months ended September 30, 2025, increased by 9.5% to $2,858,000, compared to $2,610,000 for the same period in 2024.
• Gross margin for the nine months ended September 30, 2025, was 45.4%, a slight decrease from 46.5% in the same period of 2024.
• One customer accounted for approximately 97% of net sales for the six months ended June 30, 2025, and 95% and 90% for the years ended December 31, 2024, and 2023, respectively.
• The company qualifies as an 'emerging growth company' and 'smaller reporting company,' allowing for reduced public company reporting requirements.

Sentiment

Score: 7

Explanation: The company demonstrates strong historical financial performance and a clear growth strategy in a growing market. Its unique 'UltraFresh' positioning and cold chain infrastructure provide significant competitive advantages. However, the very high customer concentration and the use of IPO proceeds for CEO share redemption introduce notable risks and reduce the overall positive sentiment.

Positives

• Demonstrated strong historical revenue growth with a 41.8% CAGR from $5.6 million in 2022 to $11.2 million in 2024.
• Achieved a 14.3% increase in net sales to $9,714,000 for the nine months ended September 30, 2025, compared to the same period in 2024.
• Reported a 9.5% improvement in net income to $2,858,000 for the nine months ended September 30, 2025, compared to the same period in 2024.
• Pioneering the 'UltraFreshTM' juice category with a unique cold-crafted process that avoids heat treatment, HPP, or UV, preserving authentic taste and nutrients.
• Possesses a proprietary end-to-end 35F cold chain infrastructure, which serves as a significant competitive advantage and barrier to entry.
• Operates with an asset-light model and has established long-term relationships with citrus growers, ensuring a consistent supply of premium fruit at competitive prices.
• The executive team brings decades of experience and established relationships with major U.S. grocery retailers, facilitating market access.
• Offers a strategic retail model that provides a comprehensive solution to retailers, eliminating their need for dedicated clean spaces, specialized equipment, and food safety management for in-store juicing.
• Targets a large and growing U.S. fruit juice market, valued at $55.5 billion in 2024 and projected to reach $77.5 billion by 2033, with a 3.8% CAGR.
• The global lemonade segment, a key product area, shows significant momentum with a $9.7 billion valuation in 2024, projected to reach $16.7 billion by 2034 (6.3% CAGR).
• Maintains strong financial discipline with a focus on profitable, responsible, and sustainable growth.
• Successfully paid off its line of credit in 2024, transitioning to net interest income for the nine months ended September 30, 2025.
• Initiated customer diversification efforts, including onboarding a new national retailer, which is a positive step towards mitigating customer concentration risk.

Negatives

• Experiences extremely high customer concentration, with one customer accounting for approximately 97% of net sales for the six months ended June 30, 2025, and 95% and 90% for the years ended December 31, 2024, and 2023, respectively.
• Gross margin slightly decreased to 45.4% for the nine months ended September 30, 2025, from 46.5% in the same period of 2024.
• Selling, general, and administrative expenses increased by 23.2% to $1,211,000 for the nine months ended September 30, 2025, compared to the same period in 2024.
• A significant portion of the IPO proceeds ($3,750,000) will be used to redeem shares from the CEO, reducing the capital available for company expansion and working capital.
• Has a limited operating history in new and evolving markets, which may make it difficult to evaluate future prospects and growth outside its current region.
• Relies on a limited number of cold chain-dependent production and distribution facilities, with no redundant manufacturing or cold chain distribution infrastructure.
• Depends on a limited number of suppliers for raw materials, creating potential supply chain disruption and cost increase risks.
• Does not intend to pay dividends on its common stock in the foreseeable future, meaning investor returns depend solely on stock price appreciation.
• New investors purchasing common stock at the assumed IPO price of $7.50 will suffer immediate and substantial dilution of $5.92 per share.
• The management team has limited experience operating a public company, which could divert their attention from day-to-day business operations.
• The CEO, Horatio Lonsdale-Hands, and other co-founders/directors will beneficially own approximately 60.77% of the outstanding common stock after the offering, allowing them to exert substantial influence over shareholder matters.

Risks

• Limited operating history in new and evolving markets may make it difficult to evaluate current business and future prospects and increases investment risk.
• Historical financial and operating results may not be indicative of future performance, and the company may not sustain historical profitability levels.
• Operates in a highly competitive beverage industry and may struggle to maintain or grow market share against larger, better-capitalized competitors.
• Success depends on the continued strength of the brand and consumer perception of product quality, safety, freshness, and healthfulness.
• Future growth relies on the successful development and acceptance of new products and product innovation.
• Reliance on a limited number of cold chain-dependent production and distribution facilities makes operations vulnerable to disruptions (e.g., mechanical failure, labor shortages, natural disasters).
• The business model's dependence on strict cold chain logistics from sourcing through delivery adds operational complexity, cost, and vulnerability to temperature excursions or logistical delays.
• Dependence on the availability, cost, and quality of fresh citrus and other raw ingredients, with agricultural or climate-related disruptions potentially affecting supply and margins.
• Production facilities must maintain compliance with rigorous food safety and regulatory standards (FDA, Juice HACCP, SQF, USDA Organic, Kosher); any lapse could result in product recalls, liability, or reputational harm.
• Risks associated with managing short shelf-life products increase exposure to inventory spoilage, write-downs, and stockouts.
• Changes in consumer preferences, particularly away from fresh juice, citrus beverages, or premium-priced fresh products, could adversely affect demand.
• The growth strategy depends on geographic expansion, which requires securing and equipping new facilities and may be costly and complex.
• High customer concentration (97% of net sales from one customer for 6 months ended June 30, 2025) means the loss or reduction of purchases from this customer would materially and adversely affect the business.
• Dependence on a limited number of suppliers for products; the loss of one or more could disrupt operations or increase costs.
• Growth depends on expanding distribution through new retail relationships and deeper penetration with existing accounts; failure to secure or maintain these relationships on favorable terms may limit revenue potential.
• Heavy reliance on third-party retailers and brokers to market and sell products; their shelf prioritization, execution, or financial health may directly impact performance.
• High-tech driven, centralized production systems are core to efficiency and quality; technical failures or cybersecurity incidents could disrupt operations or result in data loss.
• Reliance on third-party logistics providers for delivery; any breakdown or delay could damage product integrity and customer trust.
• Difficulties in forecasting demand accurately could lead to excess inventory, underproduction, missed revenue opportunities, or higher working capital needs.
• Failure to effectively manage growth, including geographic expansion and increased retail distribution, could negatively impact operations and customer experience.
• Potential legal challenges related to the accuracy of health and wellness claims.
• Future success depends on the ability to attract, retain, and develop key employees and senior leadership.
• May require additional capital to support growth strategy or operations, and such financing may not be available on acceptable terms or at all.
• Disruptions in the worldwide economy may adversely affect business, financial condition, results of operations, and cash flows.
• Climate change, or legal or market measures to address climate change, may negatively affect business and operations.
• Fluctuations in business conditions may unexpectedly impact reported results of operations and financial condition.
• Insurance may not provide adequate levels of coverage against claims or otherwise protect from all risks, or may be unavailable at reasonable cost.
• Members of the management team have limited experience in operating a public company, potentially diverting their attention from day-to-day business.
• The company will incur increased costs as a result of operating as a public company, and management will devote substantial time to new compliance initiatives.
• Food safety and food-borne illness incidents or other safety concerns may materially adversely affect the business.
• Failure to comply with federal and state laws and regulations relating to data privacy, data protection, advertising, and consumer protection could adversely affect the business.
• Litigation or legal proceedings could expose the company to significant liabilities and negatively impact its reputation or business.
• Legislative or regulatory changes that affect products, including new taxes, could reduce demand or increase costs.
• Failure to comply with requirements to design, implement, and maintain effective internal controls could have a material adverse effect on the business and stock price.
• Reliance heavily on information technology systems; any significant failure, inadequacy, interruption, or data security incident could adversely affect the business.
• May be unable to adequately protect intellectual property or may face claims of infringing the intellectual property of others.
• There has been no prior public market for the common stock; an active market may not develop or be sustainable, and shares may not be resold at or above the IPO price.
• The price of common stock may be volatile, and purchasers could incur substantial losses.
• A substantial portion of total issued and outstanding shares may be sold into the market at any time after lock-up expiration, potentially causing the market price to drop significantly.
• If the NYSE listing application for common stock is not approved, the offering will be terminated.
• Authorization to issue blank check preferred stock without stockholder approval could adversely impact the rights of common stockholders.
• As an emerging growth company, the company will not be required to comply with certain reporting requirements, which may make its common stock less attractive to some investors.
• Management will have broad discretion in the use of net proceeds from the offering and may not use them effectively.
• No intention to pay dividends on common stock; return on investment depends solely on stock price appreciation.
• No independent valuation of stock has been performed, meaning common stock may be worth less than the offering price.
• If securities industry analysts do not publish research reports or publish unfavorable reports, the market price and trading volume of common stock could be negatively affected.
• Delaware law and provisions in the certificate of incorporation and bylaws could make a merger, tender offer, or proxy contest more difficult, limit attempts to replace management, and depress the market price.
• Future issuances of debt or equity securities ranking senior to common stock may adversely affect the level of return from an investment.

Future Outlook

The company plans disciplined geographic expansion with new production facilities in South Carolina (projected 2026) and Arizona/Nevada (projected 2027) to serve a large percentage of the U.S. population. It aims to expand its multi-channel sales approach, including regional and national broker networks, and increase marketing investment to build brand awareness for its UltraFreshTM products. The vision is to make UltraFreshTM juice the new standard in every U.S. grocery store.

Management Comments

• "At Buda Juice, we started small—one RAW.ORGANIC.REAL. sip at a time. As life became busier, convenience often meant sacrificing health. Recognizing this challenge, we set out to offer delicious, genuinely fresh juices, making it effortless for people to incorporate more fruits and vegetables into their daily lives." Horatio Lonsdale-Hands, Co-Founder, CEO.
• "Buda Juice is pioneering a new category in beverages, UltraFreshTM juice, offering cold-crafted citrus-based drinks that are never heat-treated, never HPP-processed and always cold."
• "Looking ahead, we believe our opportunity is brilliant. We are not simply capturing market share—we believe we are expanding the refrigerated juice category itself by helping retailers evolve to the next generation of freshness."
• "We have demonstrated our ability to deliver high product velocity without sacrificing margins, positioning us strongly for scalable growth through our Buda Fresh and private-brand offerings across multiple channels, geographies, and formats."
• "Buda exists to redefine what fresh juice means. Our vision is to make UltraFreshTM juice the new standard, providing clean beverages in every grocery store across the U.S., without compromise on safety, taste or nutrients."
• "We are deeply proud of our journey so far and incredibly excited for the future. Thank you for joining us in pioneering a fresher and cleaner tomorrow, one bottle at a time." Horatio Lonsdale-Hands, Co-Founder, CEO.
• "We believe that our operating cash flow, access to credit facilities, and this Offering, will provide us with sufficient capability to support our growth plans."
• "We believe our relationships with growers and our asset-light supply chain model have been integral to our ability to scale efficiently and compete effectively in the marketplace."

Industry Context

The U.S. fruit juice market is substantial, valued at $55.5 billion in 2024 and projected to reach $77.5 billion by 2033, with supermarkets and hypermarkets accounting for 60-70% of sales. The global lemonade segment, a key product area for Buda Juice, is also experiencing significant growth, valued at $9.7 billion in 2024 and projected to reach $16.7 billion by 2034. Consumers, particularly Generation Z and Millennials, increasingly prioritize health, freshness, convenience, and natural ingredients in their beverage choices. The freshly squeezed juice category remains underpenetrated due to operational complexities for retailers, a gap that Buda Juice's centralized UltraFreshTM model is designed to fill by offering a unique cold-chain solution at scale, differentiating itself from traditional heat-processed, HPP, and boutique cold-pressed juice competitors.

Comparison to Industry Standards

• Buda Juice's UltraFreshTM process, which involves cold-crafted citrus-based drinks that are never heat-treated, never HPP-processed, never UV-treated, and always cold, offers an 8-12 day shelf life. This contrasts with traditional heat-processed juices (e.g., Tropicana, Minute Maid, Simply Orange) that achieve 60 days to 12 months shelf life but often degrade flavor and nutrients.
• The company's method also differs from High-Pressure Processing (HPP) technology (e.g., Suja Juice, Naked, Evolution Fresh, Bolthouse Farms), which extends shelf life to 30-90 days and maintains better nutritional content than heat processing, but still alters molecular structure and, in Buda Juice's view, cannot achieve true fresh taste.
• Buda Juice's centralized production model directly addresses the significant operational challenges, high capital investment, and inconsistent quality associated with in-store fresh-squeezed juice operations, which are currently limited to less than 5% of U.S. grocery stores.
• The company's demonstrated ability to deliver high product velocity without sacrificing margins positions it strongly for scalable growth, a key differentiator in the competitive beverage market where many players struggle to balance freshness, scale, and profitability.

Management Changes

Corporate Governance

Legal Proceedings

• Approximately six years ago, the company encountered a third-party opposition from a kombucha company named Buddha during its trademark application process in Canada. The company abandoned the Canadian application as it was not necessary for its U.S. market development strategy.
• The company is not currently a party to any material legal proceedings.

Related Party Transactions

• The company's revolving line of credit with Amegy Bank (renewed July 9, 2025, for $3,000,000, maturing July 8, 2026) is supported by personal guarantees from three members of the Board of Directors: Horatio Lonsdale-Hands (CEO), Bryan Herr (Executive Chairman), and Bernard Lucien Nussbaumer (Co-founder, Director).
• Karina Farquharson, Vice President of Marketing, is the wife of CEO Horatio Lonsdale-Hands.

Stakeholder Impact

• Shareholders: Potential for capital appreciation if the IPO is successful and growth strategy is executed, but also immediate dilution for new investors and no anticipated dividends. The concentrated ownership by existing management and directors means they will maintain significant influence over company decisions.
• Employees: Will benefit from the new 2025 Equity Incentive Plan, designed to attract, motivate, and retain personnel by aligning their interests with the company's long-term success.
• Customers (Retailers): Benefit from Buda Juice's UltraFreshTM product offering, which eliminates the operational complexities and capital investment required for in-store juicing, potentially driving store traffic and category growth. However, the high customer concentration means a single customer's decisions could significantly impact Buda Juice.
• Suppliers: Long-term relationships with citrus growers are crucial for consistent supply and competitive pricing. The company is developing contingency plans and diversifying its supplier base to mitigate concentration risk.
• Creditors: The company has paid off its line of credit and believes it has sufficient liquidity, reducing immediate credit risk. Personal guarantees from directors provide additional support for the credit facility.

Next Steps

• Consummate the statutory conversion from Buda Juice, LLC to Buda Juice, Inc. immediately before the closing of the IPO.
• Complete the Initial Public Offering (IPO) and list common stock on the NYSE under the symbol BUDA.
• Develop and furnish a new production plant in South Carolina (projected to be completed in 2026) to serve the Southeast and Mid-Atlantic regions.
• Develop and furnish a new production facility in Arizona/Nevada (projected to be completed in 2027) to serve Western U.S. markets.
• Expand the existing Dallas, Texas plant.
• Implement a multi-channel sales approach, including regional and national broker networks, and leverage leadership's industry relationships for direct retail access.
• Expand marketing and brand-building efforts through targeted education strategies, in-store demonstrations, and digital campaigns.
• Develop dedicated sales resources to pursue opportunities in complementary channels (restaurants, bars, hotels, institutional food service).
• Adopt the Buda Juice, Inc. 2025 Equity Incentive Plan upon NYSE listing, subject to stockholder approval.
• Enter into separate indemnification agreements with each director and executive officer.
• Adopt a written related person transaction policy and a clawback policy.

Key Dates

Recommendation

Buda Juice presents a compelling growth story in the expanding fresh juice market, backed by strong historical revenue and net income growth, a unique product differentiation with its UltraFreshTM cold chain, and an experienced management team. The IPO aims to fund strategic geographic expansion, which could significantly increase market reach. However, the extremely high customer concentration (97% from one customer) poses a substantial risk, making the company highly vulnerable to changes in that relationship. The immediate dilution for new investors and the use of a significant portion of IPO proceeds for CEO share redemption also warrant caution. While the long-term potential is attractive, the concentration risk suggests a 'hold' recommendation for seasoned investors, advising to monitor diversification efforts and execution of expansion plans before a stronger position.

Keywords

UltraFresh Juice, Cold-Crafted Beverages, SEC Filing, IPO, Buda Juice, Beverage Industry, Food Safety, Cold Chain Logistics, Retail Distribution, Consumer Goods, SQF Certified, Juice HACCP, Delaware Corporation, NYSE Listing, Emerging Growth Company, Private Label, Citrus Juice, Wellness Shots, Food & Beverage